Drug Pipeline

13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-22 NCT07600983 Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine… Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07333352 PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71… Pneumococcal Infectious Disease Recruiting
Phase 1/2
NCT07600983 Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine… Streptococcus Pneumoniae Infection Not Yet Recruiting
Phase 1
NCT06675032 Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years Pneumococcal Infectious Disease Active, Not Recruiting
Sponsors Running 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Trials
Shanghai Reinovax Biologics Co.,LTD (2) CanSino Biologics Inc. (1)
Get alerts when 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free